We serve Chemical Name:N-(pyridin-4-ylmethyl)acetamide CAS:23974-15-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-(pyridin-4-ylmethyl)acetamide
CAS.NO:23974-15-4
Synonyms:N-pyridin-4-ylmethyl-acetamide;N-<4-pyridylmethyl>acetamide;4-acetylaminomethylpyridine
Molecular Formula:C8H10N2O
Molecular Weight:150.17800
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:379.2ºC at 760 mmHg
Density:1.088g/cm3
Index of Refraction:1.523
PSA:41.99000
Exact Mass:150.07900
LogP:1.10860
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-pyridin-4-ylmethyl-acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-acetylaminomethylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,acetamide Use and application,acetamide technical grade,usp/ep/jp grade.
Related News: Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. N-(pyridin-4-ylmethyl)acetamide manufacturer In these situations, the API is not a single substance but the culmination of various ingredients. N-(pyridin-4-ylmethyl)acetamide supplier The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. N-(pyridin-4-ylmethyl)acetamide vendor In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. N-(pyridin-4-ylmethyl)acetamide factory Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.
